Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Parasite Makes Quick Exit When Researchers ‘Remove the Handbrake’

By Walter + Eliza Hall Institute of Medical Research | September 25, 2018

Institute researchers have discovered a way to halt the invasion of the toxoplasmosis-causing parasite into cells, depriving the parasite of a key factor necessary for its growth.

The findings are a key step in getting closer to a vaccine to protect pregnant women from the parasite Toxoplasma gondii, which carries a serious risk of miscarriage or birth defects. The parasite is common in Australia, being carried by 30 percent of the Australian population, and is transmitted by cat feces and can also be acquired from raw meat. Toxoplasma infection may also have a link to neurological disorders such as schizophrenia.

The research, published in the journal PLOS Biology, was led by Associate Professor Chris Tonkin, Dr. Alex Uboldi, and Mary-Louise Wilde from the Walter and Eliza Hall Institute.

Cut the Brakes
There are two important steps allowing Toxoplasma gondii to take hold within our body: the parasite needs to enter a host cell, and from there it replicates and spreads.

“After Toxoplasma infects humans it needs to switch off the infection machinery and switch on replication,” Tonkin said. ‘Without the ability to do this, Toxoplasma will die and be unable to cause disease. We discovered that the gene protein kinase A (PKA) is required for this switch. Without PKA, Toxoplasma can’t hold steady.”

Importance of New Technology
According to Uboldi, the discovery was made using advanced microscopy technology available at the Institute’s Centre for Dynamic Imaging.

“It wasn’t until we observed the parasite down the microscope and studied its behavior that we noticed something unexpected,” Uboldi said.

“This was fully dependent on our access to the sophisticated equipment at the Institute’s Centre for Dynamic Imaging.

Wide-ranging Implications
Wilde, a Ph.D. student at the Institute, noted that Toxoplasma gondii is closely related to parasites that cause a range of globally significant diseases, such as malaria.

“Central to all these parasites is that they need to invade host cells in order to survive,” Wilde said.

“Understanding the role that PKA plays in the Toxoplasma lifecycle could provide shinsights into the biology of other disease-causing parasites, such as Plasmodium, which causes malaria.

“PKA belongs to a class of molecules that are a really important drug target for other diseases such as cancer and diabetes. We now might be able to take our understanding of how PKA functions in these diseases to design new therapies for toxoplasmosis and infections caused by related parasites,” she said.

The research findings were supported by the National Health and Medical Research Council, an Australian Research Council fellowship and the Victorian Government.

SOURCE: Walter + Eliza Hall Institute of Medical Research


Filed Under: Infectious Disease

 

Related Articles Read More >

Axcella
Axcella touts positive results from Phase 2a long COVID study
monkeypox
3 critical monkeypox vaccine questions 
Moderna in the Drug Discovery & Development Pharma 50
Moderna inks deal with US for up to 300M omicron boosters
Vaccine
FDA greenlights 786,000 additional monkeypox vaccine doses

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50